ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS
Effective
during February 2017, the Board of Directors of Galileo Life
Sciences, Inc., formerly known as Modern Mobility Aids, Inc. a
Nevada corporation (the “Company”), in a quest for new
operational activities for the Company accepted certain
resignations of executive officers and members of the Board as
follows: (i) effective February 17, 2017, Declan French tendered
his resignation as the Chief Executive Officer and member of the
Board of Directors; and (ii) effective February 24, 2017, Preston
Shea tendered his resignation as the President and a member of the
Board of Directors. Neither Messrs. French or Shea resigned as a
result of any disagreement with the Company or any matter relating
to the Company’s operations, policies or
practices.
Previously
the following individuals tendered their respective resignations to
the Company as members of the Board of Directors: (i) John
Rosenthal effective May 15, 2015; (ii) Dr. Baseer Uddin Khan
effective April 10, 2015; and (iii) Ken (Khahn) Pham effective
April 12, 2015. Neither Messrs. Rosenthal, Khan or Pham resigned as
a result of any disagreement with the Company on any matter
relating to the Company’s operations, policies or
practices.
During
February 2017, the Board of Directors accepted certain consents and
approved the appointment of certain individuals as follows: (i)
effective February 24, 2017, Gilbert Sharpe was appointed as a
member of the Board of Directors; and (ii) effective February 28,
2017, Tito DiMarco was appointed as the President/Chief Executive
Officer and a member of the Board of Directors. Therefore, as of
the date of this Current Report, the Board of Directors consists of
the following members: Tito DiMarco, Gilbert Sharpe and Duncan
Scott.
Since
early 2017, the Company has been involved in the evaluation of
several business opportunities and the performance of a high level
of due diligence pertaining to potential merger opportunities. The
Company is confident that the synergies of management of the
potential target companies together with current management of the
Company will succeed in improving shareholder value of the
Company.
BIOGRAPHIES
Tito DiMarco.
Mr. DiMarco has over forty years of experience
as a distributor. From approximately 2001 to current date, Mr.
DiMarco has been the president of Osvaldo Inc., which has annual
sales over $5,000,000. Osvaldo is engaged in the manufacture and
distribution of organic juices and mineral water. It also is
engaged in the manufacture and distribution of Nettlemax, which is
an arthritis pain relief liniment. From approximately 2002 to
current date, Mr. DiMarco has been engaged with Maitech Associates,
Inc., which exports and imports medical equipment and parts,
including parts for the oil and gas industry, with annual sales
over $6,000,000. Mr. DiMarco graduated from York University in 1974
and served in the Canadian Army from 1969 to 1971
Gilbert Sharpe.
Mr. Sharpe was the former long-time director
of the Legal Branch of the Ontario Ministry of Health
and Long-Term Care and brings invaluable experience from a
distinguished 40-year career in legal practice and advisory
roles. Currently, Mr. Sharpe operates a boutique healthcare
advisory service following fifteen years in private practice
as a partner at several major Bay Street, Ontario law
firms.
Mr.
Sharpe offers unparalleled experience in healthcare public policy
and regulation, and intimately understands the complex realm
of evolving public and private healthcare in Canada. Through
his involvement with the Ministry of Health since 1975, and
associated work with numerous government ministries and
agencies, Mr. Sharpe has influenced some of the most important
legal issues and policy matters affecting modern health care.
This includes the development of legislation and policies to
improve the Ontario and Canadian health care system. This context
is invaluable for those who seek to impact change in
healthcare.
Internationally, Mr. Sharpe has been an advisor on healthcare
projects for the World Bank, Inter-American Bank, and the World
Health Organization. He advised on US healthcare reforms in
part during his tenure as a professor in the health law group
at Loyola University in Chicago
.
Mr.
Sharpe holds several professorships, including at the Faculty of
Law and the Institute of Health Policy, Management
and Evaluation (IHPME) at the University of Toronto. Mr.
Sharpe received his LLB and LLM from Osgoode Hall Law School.
He is also editor-in-chief of health law in Canada and the
former president of the Canadian Institute of Law and
Medicine. He has published several books, hundreds of articles,
and is a sought-after speaker at conferences.
Duncan Scott.
For the past thirty years, Dr. Scott has been
involved in the medical profession in a number of capacities. He
has a wide range of expertise and has been an expert witness for
both the Crown and defense attorneys. Among Dr. Scott’s many
professional affiliations, he is a member of the Canadian Society
of Medical Examiners, Canadian Academy of Psychiatry and Law and a
prior president of the Association of Physicians in Corrections of
Ontario. Dr. Scott has also lectured extensively across Ontario
with audiences consisting of psychiatrists, pharmacists, family
health teams and nurse practitioners. He has present to insurance
company’s disability staff to assist in their assessments of
clients and interactions with family practitioners. Dr. Scott has
been on CBC radio and television discussing various topics related
to his field of interest and is currently focusing on what he
believes to be the greatest obstacle to healthcare –
adherence to medication.
Since
approximately 2008 to current date, Dr. Scott has held a number of
appointments as follows: (i) Member of the Centre for Neuroscience,
Queen’s University, Kingston, Ontario; (ii) Forensic
Directors Group, Ontario; and (iii) Acting Clinical Director,
Regional Forensic Services Program, Providence Care, Mental Health
Services, Kingston, Ontario. Since 1991 to current date, Dr. Scott
has been an Associate Professor of Psychiatry at Queen’s
University and from 1997 to current date, Staff Privileges,
Department of Phychiatry, Kingston General Hospital.
From
approximately 2008 through 2010, Dr. Scott was the Deputy Head,
Department of Psychiatry, Hotel Dieu and Kingston General Hospital.
During this time, Dr. Scott was also the Acting Deputy Head,
Department of Psychiatry, Providence Care, Mental Health Services.
From approximately 1998 through 1999, Dr. Scott was the medical
director and chief executive officer of the Institute of
Psychotherapy, Kingston, Ontario.
Dr.
Scott has also been an independent psychiatric consultant from
approximately 2001 to current date at Brookside Youth Centre
Detention and Bayfield Residential Treatment Centre. He continues
his work as an independent expert reviewer for the Coroner’s
Office in Ontario, the Canadian Medical Protective Association and
the Ontario Ministry of Health. Dr. Scott is also an independent
psychiatric consultant for the Department of Veterans Affairs, the
Probation and Parole, Ontario, Wokers Compensation Board
Consultant, the Ministry of Corrections of Public Safety and
Security and the Ontario Addiction Treatment Centre.
Dr.
Scott has been involved in a number of research studies and
publications as follows: (i) Knowledge Translation for General
Practitioners with Respect to Psychiatric Medication; (ii) Treating
ADHD in High Risk Population; (iii) ADHD – Creating a
Database on Forensic Clients with ADHD; (iv) a Comparison of
Risk/Need Measures in a Sample of Forensic Patients; (v) PLATYPUS
Study – Clinical Trial – BMI Evaluation: Placebo and
Active Comparator Trial of Olanzapine Zydis Pills Used
Sublingually; (vi) E-STAR – Electronci Schizophrenia
Treatment Adherence Registry; and (vii) Hub Study Director of an
Open Label Assessment of the Clinical Utility of Venlafaxine
Tablets in Depression.
Dr.
Scot has been the recipient of a number of awards: (i) Ontario
Medical Student Bursary Fund (2008): (ii) Queen’s University
– Excellence in Clinical Services Award (2008); (iii) Ontario
Graduate Scholarship (1977 and 1978); and (iv) Queen’s
Graduate Award in Physiology (1976 – 1978).
Dr.
Scott earned a Bachelor of Science with Honors from Queen’s
University in 1977, a Doctor of Medicine from the University of
Toronto in 1982 and a Fellow of Royal College of Physicians and
Surgeons (Canada) in 1987.